The latest news updates from the 2024 Symposium
-
Data from PADA-1 and PHOEBE trials presented on Thursday at #SABCS21
Read More: Data from PADA-1 and PHOEBE trials presented on Thursday at #SABCS21Thursday’s General Session included findings from a study looking at fulvestrant plus palbociclib for HR+ breast cancer and results of a study of pyrotinib plus capecitabine for previously treated HER2+ metastatic breast cancer.
-
AACR distinguished lecturer discusses cell cycle discoveries leading to targeted therapies
Read More: AACR distinguished lecturer discusses cell cycle discoveries leading to targeted therapiesHelen M. Piwnica-Worms, PhD, discussed her journey from basic research to translational trials during the 2021 AACR Distinguished Lectureship in Breast Cancer Research on Thursday.
-
Debate will tackle 1-week versus 3-week whole breast radiation for early-stage breast cancer
Read More: Debate will tackle 1-week versus 3-week whole breast radiation for early-stage breast cancerDuring a debate this morning, Charlotte Coles, MBChB, PhD, will present the “Pro” argument, and Julia White, MD, will present the “Con” argument on the adoption of a new schedule for whole breast radiotherapy.